The neurofilament light chain (NfL) subunit has emerged as a biomarker for axonal injury in various neurological diseases, such as multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), and traumatic brain injury (TBI) [15]. Here, NEFL is linked to myeloid sarcoma.